The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.20 - Manufacture of pharmaceutical preparations
150 jobs Number of planned job creations
Announcement Date
19 March 2013
Employment effect (start)
Foreseen end date
31 December 2013
Description
PrimeCell, a global company working in the field of regenerative medicine, is to set up an international centre in Ostrava and to create 150 new jobs by the end of 2013. With the help of European subsidies, the centre 4MEDi-Biotech Park for Medical Innovations will develop products from human cells for the treatment of inadequately treated or incurable diseases such as multiple sclerosis, Alzheimer's disease or diabetes. The investment of the project amounted to a total of CZK 702 million.
Sources
19 March 2013: CzechInvest
Citation
Eurofound (2013), PrimeCell, Business expansion in Czechia, factsheet number 75101, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/75101.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
